TScan Therapeutics Inc.

1.26
-0.01 (-0.79%)
At close: Apr 02, 2025, 3:59 PM
1.25
-0.79%
After-hours: Apr 02, 2025, 07:28 PM EDT

TScan Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash & Equivalents 178.69M 133.36M 120.03M 161.41M 34.79M 41.76M
Short-Term Investments 111.42M 58.69M n/a n/a n/a n/a
Long-Term Investments n/a n/a 5.04M 5.2M 761K 595K
Other Long-Term Assets 6.8M 6.68M 4.83M n/a n/a n/a
Receivables n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Other Current Assets 2.61M 2.19M 4.1M 4.25M n/a n/a
Total Current Assets 292.72M 194.24M 120.03M 165.65M 36.45M 42.38M
Property-Plant & Equipment 71.6M 71.23M 69.2M 17.26M 12.53M 6.41M
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 78.4M 77.91M 79.06M 22.45M 13.29M 7M
Total Assets 371.12M 272.15M 199.09M 188.11M 49.74M 49.38M
Account Payables 4.28M 2.37M 2.91M 1.76M 2.91M 1.01M
Deferred Revenue 11.7M 10.14M 3.87M 11.41M 10.63M 912K
Short-Term Debt 4.57M 3.35M 3.68M 1.65M n/a n/a
Other Current Liabilities 6.92M 5.9M 1.11M 2.27M 959K 103K
Total Current Liabilities 35.96M 29.82M 17.3M 21.34M 17.45M 2.4M
Long-Term Debt 60.74M 26.7M 29.29M n/a -59.68M n/a
Other Long-Term Liabilities 32.21M n/a 49K 97K -59.44M 59.68M
Total Long-Term Liabilities 94.19M 91.46M 82.35M 5.99M 74.75M 64.13M
Total Liabilities 130.15M 121.28M 99.66M 27.33M 92.2M 66.52M
Total Debt 65.31M 92.43M 85.98M 6.04M 7.43M 4.89M
Common Stock 5K 5K 3K 3K 1K n/a
Retained Earnings -375.1M -247.6M -158.38M -92.16M -43.53M -17.41M
Comprehensive Income 51K n/a -0.00 -188.11M -59.68M -0.00
Shareholders Equity 240.97M 150.87M 99.43M 160.78M -42.46M -17.14M
Total Investments 111.42M 58.69M 5.04M 5.2M 761K 595K